Safety and diagnostic accuracy of intravenous accelerated high-dose dipyridamole-atropine stress echocardiography

Italian Heart Journal

Volumn 3, Issue 12, 2002, Pages 726-729

  Minardi, Giovanni ^b   Manzara, Carla C ^b   Pulignano, Giovanni ^b   Carmenini, Enrico ^b   Gaudio, Carlo ^a   Giovannini, Ezio ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Dipyridamole; Echocardiography

Indexed keywords

AMINOPHYLLINE; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPYRIDAMOLE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BLOOD PRESSURE MONITORING; BRADYCARDIA; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DRUG MEGADOSE; DRUG SAFETY; ELECTROCARDIOGRAPHY; FEMALE; HEADACHE; HEART LEFT BUNDLE BRANCH BLOCK; HEART RATE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE WALL MOTION; HUMAN; HYPOTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NAUSEA; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; SUPRAVENTRICULAR TACHYCARDIA;

ATROPINE; BLOOD PRESSURE; CORONARY DISEASE; DIPYRIDAMOLE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 0036948106     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Picano E, Lattanzi F, Masini M, Distante A, L'Abbate A. High dose dipyridamole echocardiography test in effort angina pectoris. J Am Coll Cardiol 1986; 8: 848-54.
2. Picano E, Marini C, Pirelli S, et al, on behalf of the EPIC Study Group. Safety of intravenous high-dose dipyridamole echocardiography. The Echo-Persantine International Cooperative Study Group. Am J Cardiol 1992; 70: 252-8.
3. Picano E, Landi P, Bolognese L, et al, for the EPIC Study Group. Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large-scale, multicenter trial. Am J Med 1993; 95: 608-18.
4. Camerieri A, Picano E, Landi P, et al, on behalf of the EPIC Study Group. Prognostic value of dipyridamole echocardiography early after myocardial infarction in elderly patients. Echo Persantine Italian Cooperative Study Group. J Am Coll Cardiol 1993; 22: 1809-15.
5. Severi S, Picano E, Michelassi C, et al. Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease: comparison with exercise electrocardiography. Circulation 1994; 89: 1160-73.
6. Picano E, Pingitore A, Sicari R, et al, for the EPIC Study Group. Stress echocardiographic results predict risk of reinfarction early after uncomplicated acute myocardial infarction: large-scale multicenter study. Echo-Persantine International Cooperative Study Group. J Am Coll Cardiol 1995; 26: 908-13.
7. Minardi G, Di Segni M, Manzara CC, et al. Diagnostic and prognostic value of dipyridamole and dobutamine stress echocardiography in patients with Q-wave acute myocardial infarction. Am J Cardiol 1997; 80: 847-51.
8. Coletta C, Galati A, Greco G, et al. Prognostic value of high dose dipyridamole echocardiography in patients with chronic coronary artery disease and preserved left ventricular function. J Am Coll Cardiol 1995; 26: 887-94.
9. Picano E, Ostojic M, Varga A, et al. Combined low-dose dipyridamole-dobutamine stress echocardiography to identify myocardial viability. J Am Coll Cardiol 1996; 27: 1422-8.
10. Varga A, Ostojic M, Djordjevic-Dikic A, et al. Infra-low dose dipyridamole test: a novel dose regimen for selective assessment of myocardial viability by vasodilator stress echocardiography. Eur Heart J 1996; 17: 629-34.
11. Picano E, Pingitore A, Conti U, et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography. Eur Heart J 1993; 14: 1216-22.
12. Pingitore A, Picano E, Quarta Colosso M, et al, for the EPIC and EDIC Study Groups. The atropine factor in pharmacologic stress echocardiography. Echo-Persantine (EPIC) and Echo Dobutamine International Cooperative (EDIC) Study Groups. J Am Coll Cardiol 1996; 27: 1164-70.
13. Dal Porto R, Faletra A, Picano E, Pirelli S, Moreo A, Varga A. Safety, feasibility, and diagnostic accuracy of accelerated high-dose dipyridamole stress echocardiography. Am J Cardiol 2001; 87: 520-4.
14. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67.
15. Cortigiani L, Zanetti L, Bigi R, Desideri A, Fiorentini C, Nannini E. Safety and feasibility of dobutamine and dipyridamole stress echocardiography in hypertensive patients. J Hypertens 2002; 20: 1423-9.
16. Cortigiani L, Paolini EA, Nannini E. Dipyridamole stress echocardiography for risk stratification in hypertensive patients with chest pain. Circulation 1998; 98: 2855-9.
17. Astarita C, Pàlinkas A, Nicolai E, Maresca FS, Varga A, Picano E. Dipyridamole-atropine stress echocardiography versus exercise SPECT scintigraphy for detection of coronary artery disease in hypertensives with positive exercise test. J Hypertens 2001; 19: 495-502.
18. Picano E, Bedetti G, Varga A, Cseh E. The comparable diagnostic accuracies of dobutamine stress and dipyridamole stress echocardiographies: a meta-analysis. Coron Artery Dis 2000; 11: 151-9.